Skip to content

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02279264
Enrollment
40
Registered
2014-10-31
Start date
2014-09-30
Completion date
Unknown
Last updated
2014-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Establish Normative pH Values in Neonates

Keywords

ph, RightSpot Infant, Feeding Tube, RightBio Metrics, placement, Nasogastric Tube, NG, infant

Brief summary

Objectives: 1. To validate the accuracy of pH measurements of gastric fluid by comparing the readings from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor 2. To determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG tube prior to feedings 3. To establish normative pH values for neonates

Detailed description

RightBio Metrics has developed an indicator that rapidly checks gastric pH by aspirating gastric contents into the indicator through a nasogastric (NG) or orogastric (OG), causing a color change on the indicator. The color change represents various pH levels. Most Newborn Intensive Care Units require that NG/OG placement be confirmed after initial insertion and prior to any use. The purpose of this study is to validate the accuracy of pH measurement of gastric fluid by comparing the reading from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor, and to determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG/OG tube prior to use. The gastric pH measurements will be analyzed to determine the normative pH values for neonates.

Interventions

DEVICERightSpot Infant pH Indicator

pH indicator

Sponsors

RightBio Metrics
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
24 Weeks to 40 Weeks
Healthy volunteers
No

Inclusion criteria

* Infants in the Newborn Intensive Care Unit with an NG Tube

Exclusion criteria

* Infants with congenital or genetic abnormalities * Infants with gastroschesis * Infants with upper airway abnormalities * Infants receiving any supplement or medication know to alter pH gastric contents * Infants receiving Enfamil liquid human milk fortification * Infant who are NPO status

Design outcomes

Primary

MeasureTime frame
To compare the gastric pH measurement obtained from the RightSpot Indicator to the gastric pH measurement obtained from an approved pH monitor to determine the agreement and accuracy of the two modes of measurements.12 weeks
To determine the percentage of samples obtained by the RightSpot pH Indicator that could have been used to assist in determining proper placement of the NG tube prior to use. (% of collected samples vs. uncollected)12 weeks
To determine the percentage of samples obtained by the RightSpot pH Indicator that could have been used in determining proper placement of the NG tube prior to use.(% of sample accuracy)12 weeks
The gastric pH measurements will be collected and analyzed to determine the normative pH values for neonates12 weeks

Secondary

MeasureTime frame
Residual amount (ml) at the time of testing12 weeks
Gestation age at birth12 weeks
Medications given which effect pH of gastric contents12 weeks
pH reading from gastric secretions12 weeks
Adjusted gestational age at the time of testing12 weeks
Infants weight at the time of testing12 weeks
Time infant last ate12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026